A-Alpha Bio Welcomes Heidi Hagen to Its Board of Directors
SEATTLE, June 27, 2023 /PRNewswire-PRWeb/ -- A-Alpha Bio, a synthetic biology and machine learning company that measures and engineers protein-protein interactions, announced the appointment of Heidi Hagen to their Board of Directors. Hagen will be A-Alpha Bio's first independent board member.
- Hagen, Former Chief Technical Officer of Sonoma Biotherapeutics, Joins as A-Alpha's First Independent Board Member
SEATTLE, June 27, 2023 /PRNewswire-PRWeb/ -- A-Alpha Bio , a synthetic biology and machine learning company that measures and engineers protein-protein interactions, announced the appointment of Heidi Hagen to their Board of Directors. - "We are thrilled to welcome Heidi to our Board of Directors," said David Younger, CEO and Co-Founder of A-Alpha Bio.
- Based in Seattle, Hagen will be on the ground to support and share her expertise and network with the A-Alpha Bio team.
- "I am excited to join A-Alpha Bio's Board of Directors and collaborate with this dynamic team of biologists, protein engineers, and data scientists," said Hagen.